AdnaGen AG Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	24
ISBN Number	not applicable
Product Code	GMD04717

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a AdnaGen AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
6.1 Head Office
7 Recent Developments
7.1 Product News
- 7.1.1 May 07, 2008: AdnaGen Announces The Submission Of A Request For A Pre-IDE Determination Meeting With FDA For AdnaGens AdnaTest Breast Cancer For The Detection Of Circulating Breast Tumor Cells
- 7.1.2 Oct 11, 2007: AdnaGen Signs Exclusive Agreement With Innogenetics To Develop And Commercialize New Multiplex Oncology Tests
8 AdnaGen AG Pipeline Products
8.1 AdnaGen AG Product Pipeline Analysis
- 8.1.1 AdnaGen AG Pipeline Products By Equipment Type
- 8.1.2 AdnaGen AG Pipeline Products By Development Stage
- 8.1.3 AdnaGen AG Pipeline Products By Therapy Area
- 8.1.4 AdnaGen AG Pipeline Products By Clinical Trials
- 8.1.5 AdnaGen AG Pipeline Products By News Summary
8.2 New multiplex oncology tests
- 8.2.1 Product Description
- 8.2.2 Product Status
- 8.2.3 Product Milestone
8.3 AdnaTest ColonCancer
- 8.3.1 Product Description
- 8.3.2 Product Status
- 8.3.3 Clinical Trials
- 8.3.4 Product Milestone
8.4 AdnaTest BreastCancer
- 8.4.1 Product Description
- 8.4.2 Product Status
- 8.4.3 Clinical Trials
- 8.4.4 Product Milestone
8.5 AdnaTest OvarianCancer
- 8.5.1 Product Description
- 8.5.2 Product Status
- 8.5.3 Product Patent Details
9 Appendix
9.1 Methodology
- 9.1.1 Coverage
- 9.1.2 Secondary Research
- 9.1.3 Primary Research
- 9.1.4 Expert Panel Validation
9.2 Contact Us
9.3 About Global Markets Direct
9.4 Disclaimer
1.1 List Of Tables
Table 1: AdnaGen AG,Key Facts
Table 2: AdnaGen AG, Key Employees,
Table 3: AdnaGen AG Pipeline Products by Equipment Type
Table 4: AdnaGen AG Pipeline Products By Development Stage
Table 5: AdnaGen AG Pipeline Products By Therapy Area
Table 6: AdnaGen AG Pipeline Products By Clinical Trials
Table 7: AdnaGen AG Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: AdnaGen AG Pipeline Products By Development Stage
Figure 2: Global Markets Direct Methodology